Description
About Latinib 250 Mg
Latinib 250mg tablets are formulated with Lapatinib Ditosylate Monohydrate INN and contain 250mg of Lapatinib per tablet. When administered intracellularly, lapatinib blocks the activity of the 4-anilinoquinazoline kinase. Advanced or metastatic breast cancer is a valid indication for the use of Latinib 250 mg. Combination with Capecitabine or Letrozole is recommended.
Dosage
Take five tablets of Latinib 250 mg once daily, with or without food, until disease progression. It’s best to take it either an hour before or after eating. Put the capsules in your mouth and drink the water. The capsules should not be opened, broken, or chewed. Every day, at about the same time, give yourself 250 milligrams of Latinib. Take this medication exactly as prescribed by your doctor for the best results.
Side Effects
- Diarrhea.
- Palmar-plantar erythrodysesthesia.
- Nausea.
- Rash.
- Vomiting.
Storage
Latinib 250 mg tablets should be kept in a cool (below 30 degrees Celsius), dark (away from light), and secure location where children cannot access them.
Reviews
There are no reviews yet.